Progenome Lifescience offers RTPCR services for various infectious diseases including Covid-19, HIV, HBV, HCV, and H1N1. The company also provides genetic testing for BRCA mutations. RTPCR is a highly sensitive and specific molecular diagnostic technique that detects the presence of viral or bacterial genetic material in a patient’s sample.

With Progenome Lifescience’s state-of-the-art laboratory facilities and experienced team of scientists, accurate and timely diagnosis is ensured. The company’s RTPCR services are crucial in the early detection and management of these infectious diseases, helping to reduce the spread of the virus and improve patient outcomes.